Immunostimulatory functions of adoptively transferred MDSCs in experimental blunt chest trauma.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 05 2019
Historique:
received: 18 02 2019
accepted: 14 05 2019
entrez: 31 5 2019
pubmed: 31 5 2019
medline: 21 10 2020
Statut: epublish

Résumé

Myeloid-derived suppressor cells (MDSCs) expand during inflammation and exhibit immunomodulatory functions on innate and adaptive immunity. However, their impact on trauma-induced immune responses, characterized by an early pro-inflammatory phase and dysregulated adaptive immunity involving lymphocyte apoptosis, exhaustion and unresponsiveness is less clear. Therefore, we adoptively transferred in vitro-generated MDSCs shortly before experimental blunt chest trauma (TxT). MDSCs preferentially homed into spleen and liver, but were undetectable in the injured lung, although pro-inflammatory mediators transiently increased in the bronchoalveolar lavage (BAL). Surprisingly, MDSC treatment strongly increased splenocyte numbers, however, without altering the percentage of splenic leukocyte populations. T cells of MDSC-treated TxT mice exhibited an activated phenotype characterized by expression of activation markers and elevated proliferative capacity in vitro, which was not accompanied by up-regulated exhaustion markers or unresponsiveness towards in vitro activation. Most importantly, also T cell expansion after staphylococcal enterotoxin B (SEB) stimulation in vivo was unchanged between MDSC-treated or untreated mice. After MDSC transfer, T cells preferentially exhibited a Th1 phenotype, a prerequisite to circumvent post-traumatic infectious complications. Our findings reveal a totally unexpected immunostimulatory role of adoptively transferred MDSCs in TxT and might offer options to interfere with post-traumatic malfunction of the adaptive immune response.

Identifiants

pubmed: 31142770
doi: 10.1038/s41598-019-44419-5
pii: 10.1038/s41598-019-44419-5
pmc: PMC6541619
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7992

Références

Cancer Immunol Immunother. 2011 Oct;60(10):1419-30
pubmed: 21644036
J Immunol. 2010 Jun 1;184(11):6151-60
pubmed: 20427766
J Neuroimmunol. 2016 Jan 15;290:96-102
pubmed: 26711577
Nat Immunol. 2018 Feb;19(2):108-119
pubmed: 29348500
J Immunol. 2007 Jul 15;179(2):977-83
pubmed: 17617589
Eur J Immunol. 2005 Dec;35(12):3533-44
pubmed: 16331707
Sci Rep. 2017 Oct 9;7(1):12808
pubmed: 28993671
PLoS One. 2014 Jun 13;9(6):e100013
pubmed: 24927018
Hum Immunol. 2017 Feb;78(2):113-119
pubmed: 27939507
Oncotarget. 2016 Apr 5;7(14):17565-78
pubmed: 27007050
J Exp Med. 2007 Jun 11;204(6):1463-74
pubmed: 17548519
Scand J Immunol. 2014 Feb;79(2):98-104
pubmed: 24313384
Eur J Immunol. 2009 Dec;39(12):3538-51
pubmed: 19830733
J Mol Med (Berl). 2016 Aug;94(8):911-20
pubmed: 26936474
Exp Neurol. 2016 Dec;286:50-60
pubmed: 27693617
J Immunol. 2018 Jan 15;200(2):422-431
pubmed: 29311384
J Trauma. 2007 Dec;63(6):1407-17
pubmed: 18212667
Immunity. 2010 Jun 25;32(6):790-802
pubmed: 20605485
J Immunol. 2006 Feb 15;176(4):2085-94
pubmed: 16455964
Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):1074-8
pubmed: 1899481
J Immunol. 2013 Aug 1;191(3):1073-81
pubmed: 23804709
Exp Neurol. 2010 Nov;226(1):242-53
pubmed: 20832407
Bone. 2016 Dec;93:113-124
pubmed: 27664567
Mediators Inflamm. 2015;2015:458626
pubmed: 25709155
Autoimmunity. 2017 May;50(3):170-181
pubmed: 28276713
Mucosal Immunol. 2010 Nov;3(6):578-93
pubmed: 20664577
Front Immunol. 2018 Feb 15;9:282
pubmed: 29497426
Ann Surg. 1995 Oct;222(4):482-90; discussion 490-2
pubmed: 7574928
Nat Rev Immunol. 2017 Jul;17(7):407-420
pubmed: 28436424
Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):4171-81
pubmed: 26592844
Blood. 2013 Mar 7;121(10):1740-8
pubmed: 23305737
Blood. 2015 Aug 27;126(9):1138-48
pubmed: 26185131
Infect Immun. 2012 Jun;80(6):2026-34
pubmed: 22451518
J Leukoc Biol. 2017 Sep;102(3):727-740
pubmed: 28546500
J Neurochem. 2013 Apr;125(1):74-88
pubmed: 23278273
J Immunol. 2016 Feb 1;196(3):1132-45
pubmed: 26712947
Nat Immunol. 2018 Apr;19(4):327-341
pubmed: 29507356
PLoS One. 2011;6(9):e25242
pubmed: 21966467
Circulation. 2018 Jul 10;138(2):181-197
pubmed: 29437117
Cytokine. 2016 Dec;88:214-221
pubmed: 27676155
Oncoimmunology. 2015 Oct 14;5(2):e1004983
pubmed: 27057424
Clin Transl Immunology. 2016 Apr 29;5(4):e77
pubmed: 27195120
Clin Sci (Lond). 2016 Aug 1;130(16):1453-67
pubmed: 27231253
J Leukoc Biol. 2012 Dec;92(6):1199-206
pubmed: 23077247
Arthritis Rheumatol. 2016 Nov;68(11):2717-2727
pubmed: 27214349
J Leukoc Biol. 2014 Nov;96(5):675-84
pubmed: 24948701
Sci Rep. 2016 Mar 04;6:22658
pubmed: 26939768
Trends Immunol. 2011 Jan;32(1):19-25
pubmed: 21067974
Oncol Lett. 2017 Aug;14(2):1766-1774
pubmed: 28789407

Auteurs

Monika Kustermann (M)

Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

Malena Klingspor (M)

Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

Markus Huber-Lang (M)

Institute of Clinical and Experimental Trauma-Immunology, University Medical Center Ulm, Ulm, Germany.

Klaus-Michael Debatin (KM)

Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

Gudrun Strauss (G)

Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany. gudrun.strauss@uniklinik-ulm.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH